HTSUF
Price:
$29
Market Cap:
$302.08B
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HA...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-09-23
Stock Exchange
OTC
Ticker
HTSUF
According to Hisamitsu Pharmaceutical Co., Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 16.76. This represents a change of -8.18% compared to the average of 18.25 of the last 4 quarters.
The mean historical PE Ratio of Hisamitsu Pharmaceutical Co., Inc. over the last ten years is 27.94. The current 16.76 PE Ratio has changed 5.90% with respect to the historical average. Over the past ten years (40 quarters), HTSUF's PE Ratio was at its highest in in the May 2020 quarter at 975.66. The PE Ratio was at its lowest in in the February 2025 quarter at 9.53.
Average
27.94
Median
24.47
Minimum
14.29
Maximum
59.27
Discovering the peaks and valleys of Hisamitsu Pharmaceutical Co., Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 178.98%
Maximum Annual PE Ratio = 59.27
Minimum Annual Increase = -48.07%
Minimum Annual PE Ratio = 14.29
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 14.29 | -33.76% |
| 2024 | 21.57 | -16.42% |
| 2023 | 25.81 | -16.13% |
| 2022 | 30.78 | -48.07% |
| 2021 | 59.27 | 178.98% |
| 2020 | 21.25 | -11.13% |
| 2019 | 23.91 | -29.42% |
| 2018 | 33.87 | 35.30% |
| 2017 | 25.03 | 6.14% |
| 2016 | 23.59 | 15.82% |
The current PE Ratio of Hisamitsu Pharmaceutical Co., Inc. (HTSUF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
20.56
5-year avg
30.34
10-year avg
27.94
Hisamitsu Pharmaceutical Co., Inc.’s PE Ratio is less than Dermapharm Holding SE (19.20), greater than Tsumura & Co. (11.21), less than China Medical System Holdings Limited (17.91), greater than Sihuan Pharmaceutical Holdings Group Ltd. (-138.39), greater than Curaleaf Holdings, Inc. (-8.25), less than Fagron N.V. (17.88), less than Almirall, S.A. (129.63), greater than CanSino Biologics Inc. (-115.09), greater than HUTCHMED (China) Limited (5.30), less than BioArctic AB (publ) (28.04),
| Company | PE Ratio | Market cap |
|---|---|---|
| 19.20 | $2.13B | |
| 11.21 | $1.72B | |
| 17.91 | $3.26B | |
| -138.39 | $1.92B | |
| -8.25 | $2.01B | |
| 17.88 | $1.72B | |
| 129.63 | $2.87B | |
| -115.09 | $1.55B | |
| 5.30 | $3.15B | |
| 28.04 | $2.89B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hisamitsu Pharmaceutical Co., Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hisamitsu Pharmaceutical Co., Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hisamitsu Pharmaceutical Co., Inc.'s PE Ratio?
How is the PE Ratio calculated for Hisamitsu Pharmaceutical Co., Inc. (HTSUF)?
What is the highest PE Ratio for Hisamitsu Pharmaceutical Co., Inc. (HTSUF)?
What is the 3-year average PE Ratio for Hisamitsu Pharmaceutical Co., Inc. (HTSUF)?
What is the 5-year average PE Ratio for Hisamitsu Pharmaceutical Co., Inc. (HTSUF)?
How does the current PE Ratio for Hisamitsu Pharmaceutical Co., Inc. (HTSUF) compare to its historical average?